Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Pfizer
Pfizer
Turning Point Therapeutics, Inc.
NeoImmuneTech
Replimune Inc.
Avenzo Therapeutics, Inc.
Auricula Biosciences Inc.
DualityBio Inc.
Inhibrx Biosciences, Inc
Tanabe Pharma America, Inc.
CRISPR Therapeutics
Hookipa Biotech GmbH
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Numab Therapeutics AG
HiberCell, Inc.
Intensity Therapeutics, Inc.
Vaccinex Inc.
Iovance Biotherapeutics, Inc.
Simcha IL-18, Inc.
Atara Biotherapeutics
BeiGene
Elucida Oncology
Kyowa Kirin Co., Ltd.
Evopoint Biosciences Inc.
CARsgen Therapeutics Co., Ltd.
Bristol-Myers Squibb
MedImmune LLC
NBE-Therapeutics AG
Kineta Inc.
Genelux Corporation
Vaccinex Inc.
Genocea Biosciences, Inc.
Tarveda Therapeutics
Rexahn Pharmaceuticals, Inc.
Eisai Inc.
Sinocelltech Ltd.
Generic Devices Consulting, Inc.
Eli Lilly and Company
Hanmi Pharmaceutical Company Limited
AVEO Pharmaceuticals, Inc.
Ligand Pharmaceuticals
Pfizer
Aegera Therapeutics